Heart disease is a danger like no other, meaning proper diagnosis is of paramount importance. PET scans have been, and continue to be, the best way to get such a diagnosis.

Full Text

POSITRON ANNOUNCES SALE OF ATTRIUS PET SCANNER

Niagara Falls, NY –September 5, 2018 – Positron Corporation (OTC:POSC)(the “Company”), a nuclear medicine healthcare company, is pleased to announce the sale of its Attrius PET scanner to a prominent cardiology practice in the US as they expand their services to... Read More

POSITRON APPOINTS NEW MANAGEMENT

ADEL ABDULLAH PRESIDENT & AARON HARGRAVE VICE PRESIDENT

Niagara Falls, NY –August 2, 2018– Positron Corporation (OTC:POSC)(the “Company”), a nuclear medicine healthcare company, announces the appointment of Adel Abdullah  as its President. Mr. Abdullah will also serve as a... Read More

The Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) Cardiovascular Council and the American Society of Nuclear Cardiology (ASNC) have issued the joint position paper, Clinical Quantification of Myocardial Blood Flow Using PET, which was jointly published in the Journal of Nuclear Cardiology and The... Read More

The American Society of Nuclear Cardiology (ASNC) has published an updated consensus statement on evidence-based treatment of stress myocardial perfusion imaging (MPI) in women. The consensus statement, “Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease—state-of-the-art... Read More

The American College of Radiology (ACR), together with over 300 stakeholder organizations in the Ad Hoc Group for Medical Research, helped to realize research funding goals in the new $1.3 trillion federal budget bill passed by Congress March 22 and signed one day later by President Donald Trump.

Full Text... Read More